高密度钙化1K斑块与急性冠脉综合征风险的相关性
本研究为多中心巢式病例对照研究,纳入189例发生ACS的患者与189例倾向性评分匹配的对照,基于CCTA定量分析斑块体积。结果显示,ACS患者1K斑块(>1000 HU)体积显著低于对照,且1K斑块与未来ACS风险降低相关,提示其可能改善风险分层。
要点
- 1K斑块(>1000 HU)体积较高与未来ACS风险降低相关。
- 总体钙化斑块体积在ACS患者与对照间无显著差异。
- 1K斑块测量可能超越斑块负荷改善风险分层。
核心结论
- 在患者水平和病变水平上,1K斑块与未来ACS风险降低相关。
研究设计与样本
- 多中心巢式病例对照研究,纳入189例CCTA后发生ACS患者与189例匹配对照,1:1倾向性评分匹配。
关键数值与推荐
- 低密度斑块定义为<130 HU,钙化斑块定义为>350 HU,并分为351-700 HU、701-1000 HU和>1000 HU(1K斑块)三层。
临床怎么用
- CCTA测量1K斑块可能辅助识别ACS低风险人群,优化风险分层。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Plaque morphologic measures on coronary computed tomography angiography (CCTA) have been associated with future acute coronary syndrome (ACS). However, the evolution of calcified coronary plaques by noninvasive imaging is not known. OBJECTIVE: To ascertain whether the increasing density in calcified coronary plaque is associated with risk for ACS. DESIGN, SETTING, AND PARTICIPANTS: This multicenter case-control cohort study included individuals enrolled in ICONIC (Incident Coronary Syndromes Identified by Computed Tomography), a nested case-control study of patients drawn from the CONFIRM (Coronary CT Angiography Evaluation for Clinical Outcomes: An International Multicenter) registry, which included 13 study sites in 8 countries. Patients who experienced core laboratory-verified ACS after baseline CCTA (n = 189) and control individuals who did not experience ACS after baseline CCTA (n = 189) were included. Patients and controls were matched 1:1 by propensity scores for age; male sex; presence of hypertension, hyperlipidemia, and diabetes; family history of premature coronary artery disease (CAD); current smoking status; and CAD severity. Data were analyzed from November 2018 to March 2019. EXPOSURES: Whole-heart atherosclerotic plaque volume was quantitated from all coronary vessels and their branches. For patients who underwent invasive angiography at the time of ACS, culprit lesions were coregistered to baseline CCTA lesions by a blinded independent reader. Low-density plaque was defined as having less than 130 Hounsfield units (HU); calcified plaque, as having more than 350 HU and subcategorized on a voxel-level basis into 3 strata: 351 to 700 HU, 701 to 1000 HU, and more than 1000 HU (termed 1K plaque). MAIN OUTCOMES AND MEASURES: Association between calcium density and future ACS risk. RESULTS: A total of 189 patients and 189 matched controls (mean [SD] age of 59.9 [9.8] years; 247 [65.3%] were male) were included in the analysis and were monitored during a mean (SD) follow-up period of 3.9 (2.5) years. The overall mean (SD) calcified plaque volume (>350 HU) was similar between patients and controls (76.4 [101.6] mm3 vs 99.0 [156.1] mm3; P = .32), but patients who experienced ACS exhibited less 1K plaque (>1000 HU) compared with controls (3.9 [8.3] mm3 vs 9.4 [23.2] mm3; P = .02). Individuals within the highest quartile of 1K plaque exhibited less low-density plaque, as a percentage of total plaque, when compared with patients within the lower 3 quartiles (12.6% [10.4%] vs 24.9% [20.6%]; P < .001). For 93 culprit precursor lesions detected by CCTA, the volume of 1K plaque was lower compared with the maximally stenotic lesion in controls (2.6 [7.2] mm3 vs 7.6 [20.3] mm3; P = .01). The per-patient and per-lesion results were similar between the 2 groups when restricted to myocardial infarction cases. CONCLUSIONS AND RELEVANCE: Results of this study suggest that, on a per-patient and per-lesion basis, 1K plaque was associated with a lower risk for future ACS and that measurement of 1K plaque may improve risk stratification beyond plaque burden.
引用
- van Rosendael AR, Narula J, Lin FY, et al. Association of High-Density Calcified 1K Plaque With Risk of Acute Coronary Syndrome. JAMA Cardiol. 2020. PMID: 31968065. doi:10.1001/jamacardio.2019.5315
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。